Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000334575 | SCV000393836 | uncertain significance | Tay-Sachs disease | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000334575 | SCV000795436 | uncertain significance | Tay-Sachs disease | 2017-11-16 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000334575 | SCV001416526 | uncertain significance | Tay-Sachs disease | 2022-02-28 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 345 of the HEXA protein (p.Gly345Ser). This variant is present in population databases (rs775322979, gnomAD 0.002%). This missense change has been observed in individual(s) with clinical features of ataxia (PMID: 29482223). ClinVar contains an entry for this variant (Variation ID: 317044). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV000334575 | SCV002085686 | uncertain significance | Tay-Sachs disease | 2019-01-02 | no assertion criteria provided | clinical testing |